MAZUMDAR CLAIRE (Chief Executive Officer) sold 2.7% of their position (10K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $279.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001470831-26-000813
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-10K
Net shares
Net seller
$279.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$3.79
Trade value
$37.90K
% of position
2.8%
8/10/2026
362.15K→372.15K
Common Stock
Direct
Shares
−10K
Price / share
$27.98
Trade value
$279.75K
% of position
2.7%
8/10/2026
372.15K→362.15K
Total
Net shares
+0.00
Net value
-$241.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | M · Option Exercise | +10K | $3.79 | $37.90K | 2.8% | 362.15K | 372.15K |
| Common Stock Direct | 8/10/2026 | S · Sale | −10K | $27.98 | $279.75K | 2.7% | 372.15K | 362.15K |
| Total | +0.00 | -$241.85K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
3.7898
Held after
110.55K
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 8/10/2026 | M · Option Exercise | −10K | 3.7898 | — | 110.55K |